Industry: Pharmaceuticals, Biotechnology
Raven biotechnologies, inc. (www.ravenbio.com) is a privately held biotechnology company focused on the simultaneous discovery of novel cell- surface drug targets and the antibody therapeutics to regulate them. Raven’s integrated approach is based on proprietary, human tissue-specific progenitor and tumor stem cell lines developed at Raven, plus proprietary methods optimized for producing MAbs targeting cell-surface proteins. This platform rapidly identifies target antigens and therapeutic candidates in their native configuration in the intact cell membrane. The Company has identified candidate therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian ( www.ravenbio.com )
Raven Biotechnologies , Inc.
1140 Veterans Blvd.
South San Francisco, California 94080
USA
Tel: (650) 624-2600
Fax: (650) 553-9169